Next Article in Journal
Fragment C of Tetanus Toxin: New Insights into Its Neuronal Signaling Pathway
Previous Article in Journal
Determination of Aniline and Its Derivatives in Environmental Water by Capillary Electrophoresis with On-Line Concentration
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Opinion

Inflammation Amplification by Versican: The First Mediator

1
Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, China
2
Department of Pharmacology, Zhejiang Chinese Medical University, Hangzhou 310053, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2012, 13(6), 6873-6882; https://doi.org/10.3390/ijms13066873
Submission received: 20 April 2012 / Revised: 3 May 2012 / Accepted: 29 May 2012 / Published: 6 June 2012
(This article belongs to the Section Biochemistry)

Abstract

The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps of inflammation. Versican, a ubiquitous component of the ECM, contributes to the formation of the inflammatory response and is highly regulated by cytokines. Certain cytokines exert their initial effects on versican to alter the homeostasis of the inflammatory milieu, and inappropriate production of versican may promote the next inflammatory response. Therefore, versican could be the first step in the amplification of the inflammatory response, and ongoing research of this molecule may help to explain the pathogenesis of inflammation.
Keywords: versican; cytokines; extracellular matrix homeostasis; inflammation amplification versican; cytokines; extracellular matrix homeostasis; inflammation amplification

Share and Cite

MDPI and ACS Style

Zhang, Z.; Miao, L.; Wang, L. Inflammation Amplification by Versican: The First Mediator. Int. J. Mol. Sci. 2012, 13, 6873-6882. https://doi.org/10.3390/ijms13066873

AMA Style

Zhang Z, Miao L, Wang L. Inflammation Amplification by Versican: The First Mediator. International Journal of Molecular Sciences. 2012; 13(6):6873-6882. https://doi.org/10.3390/ijms13066873

Chicago/Turabian Style

Zhang, Zhenwei, Lei Miao, and Lianghua Wang. 2012. "Inflammation Amplification by Versican: The First Mediator" International Journal of Molecular Sciences 13, no. 6: 6873-6882. https://doi.org/10.3390/ijms13066873

APA Style

Zhang, Z., Miao, L., & Wang, L. (2012). Inflammation Amplification by Versican: The First Mediator. International Journal of Molecular Sciences, 13(6), 6873-6882. https://doi.org/10.3390/ijms13066873

Article Metrics

Back to TopTop